Global Surgical Robots Market Accelerates as Minimally Invasive Procedures and Robotic-Assisted Surgery Gain Momentum

Global Surgical Robots Market Overview

The Global Surgical Robots Market is witnessing significant expansion as hospitals and surgeons increasingly adopt robotic-assisted platforms to improve surgical precision, visualization, dexterity, and minimally invasive treatment. According to Maximize Market Research, the market was valued at USD 71.94 billion in 2022 and is expected to grow at a CAGR of 8.11% from 2023 to 2029, reaching nearly USD 124.18 billion by 2029. The market's growth is supported by rising demand for minimally invasive procedures, increasing adoption of advanced surgical technologies, and growing applications of robotic systems across complex procedures.

Surgical robots provide surgeons with enhanced depth perception, improved control, precision, and the ability to perform complex procedures through smaller incisions. Growing awareness of the clinical and operational advantages of minimally invasive surgery is encouraging hospitals to invest in robotic systems. Increasing healthcare expenditure, rising prevalence of chronic diseases, an aging population, and demand for shorter hospital stays are further strengthening adoption. The expanding use of robotics in oncology, laparoscopy, urology, gynecology, orthopedics, and other specialties is creating substantial opportunities for manufacturers.

Technological innovation is expected to remain a major market opportunity. AI-assisted navigation, advanced imaging, force feedback, computer-assisted planning, autonomous or semi-autonomous functions, and data-driven surgical platforms are improving the capabilities of robotic systems. As these technologies mature, manufacturers can target procedures that previously relied predominantly on conventional surgical techniques, while hospitals can use robotic platforms to improve workflow consistency and expand minimally invasive surgical capacity.

* Download the Full Market Report: https://www.maximizemarketresearch.com/request-sample/22528/ 

U.S. Market Trends and Investment

The United States remains a critical market for surgical robotics because of its advanced healthcare infrastructure, high adoption of minimally invasive procedures, strong medical-device ecosystem, and substantial investment in surgical innovation. During 2025, leading companies continued expanding their robotic portfolios. Stryker showcased new Mako SmartRobotics capabilities across hip, knee, spine, and shoulder procedures at the 2025 AAOS Annual Meeting, including an expanded Mako Total Hip application for robotic hip revision procedures. Medtronic also received U.S. FDA clearance for its Hugo robotic-assisted surgery system for urologic procedures in December 2025, adding another major robotic platform to the U.S. market. Meanwhile, Zimmer Biomet announced a proposed approximately $177 million acquisition of Monogram Technologies in July 2025 to strengthen its robotics portfolio with semi-autonomous and future fully autonomous orthopedic technologies.

Market Segmentation

By Application Area, the Others segment dominated the Global Surgical Robots Market, accounting for nearly 36% of total revenue in 2021. The segment includes oncology, laparoscopy, and various other general surgical procedures. Increasing demand for minimally invasive laparoscopic surgery and the growing use of robotic systems in cancer-related procedures are supporting its leading position.

The report segments the market by New Approaches, Application Area, and Product & Service. New approaches include in-vivo robots, nanobots, and capsule robots, while product and service categories include instruments and accessories, robotic systems, and services. Robotic systems are further categorized into laparoscopy, orthopedic, neurosurgical, and other systems.

Key Players 
1. Robotic-Assisted Surgical System Manufacturers
These companies develop complete robotic platforms, robotic arms, visualization systems, and minimally invasive surgery solutions.
North America
1. Intuitive Surgical, Inc. – United States
2. Medtronic plc – United States/Ireland operations
3. Johnson & Johnson (Auris Health & Verb Surgical) – United States
4. Asensus Surgical, Inc. – United States
5. Medrobotics Corporation – United States
6. Titan Medical Inc. – Canada
Europe
7. CMR Surgical Ltd. – United Kingdom
8. avateramedical GmbH – Germany
9. Microsure B.V. – Netherlands
10. Preceyes B.V. – Netherlands
Asia-Pacific
11. Medicaroid Corporation – Japan
12. China National Scientific Instruments and Materials Corporation (CSIMC) – China

2. Orthopedic Robotic Surgery & Navigation System Providers
These companies specialize in robotic systems for orthopedic procedures, including knee, hip, and spinal surgeries.
North America
1. Stryker Corporation – United States
2. Zimmer Biomet Holdings, Inc. – United States
3. THINK Surgical, Inc. – United States
4. OMNI Life Science, Inc. – United States
Europe
5. Smith+Nephew plc – United Kingdom

3. Robotic Imaging, Navigation & Precision Surgical Technology Providers
These companies provide robotic guidance, navigation, imaging, and precision control technologies for specialized surgeries.
North America
1. Corindus Vascular Robotics, Inc. – United States (acquired by Siemens Healthineers)
Europe
2. Renishaw plc – United Kingdom

* Download the Full Market Report: https://www.maximizemarketresearch.com/request-sample/22528/ 

Competitive Analysis

The Maximize Market Research report identifies Intuitive Surgical, Stryker Corporation, Medtronic, Auris Health, and Medrobotics Corporation among the key companies operating in the Global Surgical Robots Market. The broader competitive landscape also includes Think Surgical, Verb Surgical, OMNI Life Science, Zimmer Biomet, Asensus Surgical, Corindus Vascular Robotics, Renishaw, CMR Surgical, Smith & Nephew, China National Scientific Instruments and Materials Corporation, Microsure, Preceyes, Titan Medical, Avateramedical, and Medicaroid.

Intuitive Surgical continues to strengthen its robotic surgery ecosystem through next-generation platforms. Its da Vinci 5 system received FDA clearance in the U.S., introducing technologies designed to improve robotic-assisted surgery, while further regulatory developments have expanded the platform's capabilities.

Stryker Corporation is expanding the Mako platform across orthopedic specialties. In 2025, the company highlighted Mako applications for hip, knee, spine, and shoulder procedures and introduced robotic capabilities for challenging hip-revision procedures.

Medtronic strengthened competition in the soft-tissue robotic surgery market after the FDA cleared its Hugo RAS system for urologic procedures in the United States in December 2025. The system is designed to integrate with Medtronic's broader surgical portfolio and connected operating-room technologies.

Zimmer Biomet significantly increased its focus on autonomous orthopedic robotics through its 2025 acquisition of Monogram Technologies. Monogram's CT-based, AI-navigated semi-autonomous knee technology received FDA 510(k) clearance in March 2025, while development of a fully autonomous version continued.

Auris Health remains part of the competitive landscape identified by MMR, with its robotic technology contributing to the broader development of robotic-assisted minimally invasive procedures and expanding competition in advanced surgical platforms.

Regional Analysis

United States: The U.S. is one of the most important markets for surgical robotics, supported by advanced hospitals, high healthcare expenditure, strong medical-device companies, and rapid adoption of robotic-assisted procedures. Continued FDA clearances and investment by leading companies are broadening the range of procedures suitable for robotic assistance.

China: China represents an important growth opportunity as hospitals modernize surgical infrastructure and healthcare providers increasingly adopt advanced medical technologies. The country's large patient population, expanding healthcare infrastructure, and increasing focus on high-end medical equipment create favorable conditions for robotic surgery adoption.

Japan: Japan's aging population and sophisticated healthcare system create strong demand for technologies capable of supporting complex procedures and improving surgical efficiency. The presence of robotics expertise and advanced medical-device capabilities also supports the country's long-term market potential.

Conclusion

The Global Surgical Robots Market is projected to increase from USD 71.94 billion in 2022 to nearly USD 124.18 billion by 2029, expanding at a CAGR of 8.11%.

In my view, the strongest growth opportunity will come from the convergence of robotics, artificial intelligence, advanced imaging, surgical navigation, and autonomous technologies. As healthcare providers seek more precise and minimally invasive procedures, robotic platforms will increasingly move beyond conventional applications into broader specialties. Lowering system costs, expanding clinical indications, improving surgeon training, and demonstrating measurable clinical and economic outcomes will be particularly important for wider adoption. The companies that successfully combine robotic precision with AI-driven assistance, flexible platforms, and integrated surgical data ecosystems are likely to capture the strongest opportunities in the next phase of market development.

About Maximize Market Research

Maximize Market Research Pvt. Ltd. (MMR) is a global market research and consulting firm known for delivering accurate, actionable, and data-driven insights. Our expertise spans diverse industries — including medical devices, pharmaceuticals, technology, automotive, electronics, chemicals, personal care, and consumer goods. We provide services such as market-validated forecasts, competitive intelligence, strategic consulting, and industry impact analysis, helping businesses navigate market complexities and achieve sustainable growth.

Contact Maximize Market Research

MAXIMIZE MARKET RESEARCH PVT. LTD.
2nd Floor, Naval IT Park Phase 3,
Pune-Bangalore Highway, Narhe,
Pune, Maharashtra 411041, India.
📞 +91 9607365656
📧 sales@maximizemarketresearch.com